Date Title Description PDF
31 Jul 2024 On P&L The Company releases the press release related to the first half 2024 financial results Download
31 Jul 2024 On P&L The Company releases the first half 2024 financial results presentation Download
26 Jun 2024 On corporate transactions ROVI notes the recent press speculation and informs about the assessment of potential strategic alternatives Download
24 Jun 2024 On business and financial situation ROVI publishes the press release in relation to information and guidance on its strategic plan for expansion and growth Download
08 May 2024 On P&L The Company releases the press release related to the first three months of 2024 financial results Download

Pages

Date Title Description PDF
24 May 2024 Share buy-back , stabilisation and treasury stock programmes Share Buyback Program: transactions conducted between 17 May and 23 May 2024 Download
21 May 2024 Announcement of general shareholders’ meeting Publication of the announcement of the call to the General Shareholders’ Meeting and the documentation related thereto.   Download
17 May 2024 Share buy-back , stabilisation and treasury stock programmes Share Buyback Program: transactions conducted between 10 May and 16 May 2024 Download
10 May 2024 Share buy-back , stabilisation and treasury stock programmes Share Buyback Program: transactions conducted between 2 May and 9 May 2024 Download
08 May 2024 Announcement of General Shareholders’ Meeting The Company announces the decision of its Board of Directors to convene the Ordinary General Shareholders' Meeting Download

Pages

Date Title Description PDF
26 Feb 2019 Información sobre resultados ROVI releases the presentation related to the full year 2018 results Download
26 Feb 2019 Información sobre resultados ROVI releases the press release related to the full year 2018 results Download
15 Feb 2019 Others on business performance and financial information ROVI acquires rights to Dexchlorpheniramine Maleate in the Spanish and French markets Download
09 Jan 2019 Others on business performance and financial information ROVI informs about the adquisition of Falithrom® for the German market Download
08 Jan 2019 Liquidity contracts and specialists Liquidity contract: transactions conducted in the fourth quarter of 2018 Download

Pages